Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Oct 13, 2016 (10 years ago)

AHP NIFEdipine Capsules

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Presence of Foreign Tablets/Capsules

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

AHP NIFEdipine Capsules, 10mg USP, 100 count carton (NDC: 68084-022-01); Individual Blister (NDC: 68084-022-11), Rx Only, Manufactured by: Actavis Elizabeth, LLC, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217

Affected NDCs 68084-0022-01 68084-0022-11

Compare with the code on your package — it is the most precise check available.

Drug: Nifedipine Category: Blood Pressure Medication

Recalling firm
Amerisource Health Services
Origin
OH, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0144-2017 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Nifedipine recalls

See all
Class II · Moderate risk

Nifedipine USP for prescription compounding

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Terminated Stability / shelf life American Pharmaceutical Ingredients LLC NDC 58597-8025-2 D-0513-2018
Class III · Low risk

Adalat CC (nifedipine)

Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

Terminated Cross-contamination Alvogen, Inc D-0635-2017
Class III · Low risk

Adalat CC (nifedipine)

Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

Terminated Cross-contamination Alvogen, Inc D-0634-2017

Other recalls by Amerisource Health Services

All 2016 recalls
Class III · Low risk

Primidone Tablets

Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

Ongoing Cross-contamination Amerisource Health Services LLC D-0537-2026
Class III · Low risk

Primidone Tablets

Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

Ongoing Cross-contamination Amerisource Health Services LLC D-0536-2026
Class II · Moderate risk

Oxycodone Hydrochloride Tablets

Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities.

Ongoing Packaging defect Amerisource Health Services LLC NDC 68084-354-01 D-0338-2026